BioGeneration Ventures BV has raised about €25 million at the first close of a new fund targeting innovative life science companies in Europe with a strong focus on the Netherlands. The target size of the fund is €50 million. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
